The known unknowns of T cell immunity to COVID-19

Clinical and immunological features of severe and moderate coronavirus disease 2019

Chen, G., Wu, D., Guo, W., Cao, Y., Huang, D., Wang, H., Wang, T., Zhang, X., Chen, H., Yu, H., et al. (2020) · Journal of Clinical Investigation · doi:10.1172/jci137244 · Cited by 4,750 · see citing works

Imbalanced Host Response to SARS-CoV-2 Drives Development of COVID-19

Blanco-Melo, D., Nilsson-Payant, B. E., Liu, W.-C., Uhl, S., Hoagland, D., Møller, R., Jordan, T. X., Oishi, K., Panis, M., Sachs, D., et al. (2020) · Cell · doi:10.1016/j.cell.2020.04.026 · Cited by 4,222 · see citing works

Targets of T Cell Responses to SARS-CoV-2 Coronavirus in Humans with COVID-19 Disease and Unexposed Individuals

Grifoni, A., Weiskopf, D., Ramirez, S. I., Mateus, J., Dan, J. M., Moderbacher, C. R., Rawlings, S. A., Sutherland, A., Premkumar, L., Jadi, R. S., et al. (2020) · Cell · doi:10.1016/j.cell.2020.05.015 · Cited by 3,595 · see citing works

An mRNA Vaccine against SARS-CoV-2 — Preliminary Report

Jackson, L. A., Anderson, E. J., Rouphael, N. G., Roberts, P. C., Makhene, M., Coler, R. N., McCullough, M. P., Chappell, J. D., Denison, M. R., Stevens, L. J., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa2022483 · Cited by 3,237 · see citing works

Impaired type I interferon activity and inflammatory responses in severe COVID-19 patients

Hadjadj, J., Yatim, N., Barnabei, L., Corneau, A., Boussier, J., Smith, N., Péré, H., Charbit, B., Bondet, V., Chenevier-Gobeaux, C., et al. (2020) · Science · doi:10.1126/science.abc6027 · Cited by 2,984 · see citing works

Autoantibodies against type I IFNs in patients with life-threatening COVID-19

Bastard, P., Rosen, L. B., Zhang, Q., Michailidis, E., Hoffmann, H.-H., Zhang, Y., Dorgham, K., Philippot, Q., Rosain, J., Béziat, V., et al. (2020) · Science · doi:10.1126/science.abd4585 · Cited by 2,662 · see citing works

Inborn errors of type I IFN immunity in patients with life-threatening COVID-19

Zhang, Q., Bastard, P., Liu, Z., Le Pen, J., Moncada-Velez, M., Chen, J., Ogishi, M., Sabli, I. K. D., Hodeib, S., Korol, C., et al. (2020) · Science · doi:10.1126/science.abd4570 · Cited by 2,229 · see citing works

SARS-CoV-2 vaccines in development

Krammer, F. (2020) · Nature · doi:10.1038/s41586-020-2798-3 · Cited by 2,098 · see citing works

COVID-19 vaccine BNT162b1 elicits human antibody and TH1 T cell responses

Sahin, U., Muik, A., Derhovanessian, E., Vogler, I., Kranz, L. M., Vormehr, M., Baum, A., Pascal, K., Quandt, J., Maurus, D., et al. (2020) · Nature · doi:10.1038/s41586-020-2814-7 · Cited by 1,977 · see citing works

SARS-CoV-2-specific T cell immunity in cases of COVID-19 and SARS, and uninfected controls

Le Bert, N., Tan, A. T., Kunasegaran, K., Tham, C. Y. L., Hafezi, M., Chia, A., Chng, M. H. Y., Lin, M., Tan, N., Linster, M., et al. (2020) · Nature · doi:10.1038/s41586-020-2550-z · Cited by 1,887 · see citing works

Antigen-Specific Adaptive Immunity to SARS-CoV-2 in Acute COVID-19 and Associations with Age and Disease Severity

Rydyznski Moderbacher, C., Ramirez, S. I., Dan, J. M., Grifoni, A., Hastie, K. M., Weiskopf, D., Belanger, S., Abbott, R. K., Kim, C., Choi, J., et al. (2020) · Cell · doi:10.1016/j.cell.2020.09.038 · Cited by 1,790 · see citing works

Robust T Cell Immunity in Convalescent Individuals with Asymptomatic or Mild COVID-19

Sekine, T., Perez-Potti, A., Rivera-Ballesteros, O., Strålin, K., Gorin, J.-B., Olsson, A., Llewellyn-Lacey, S., Kamal, H., Bogdanovic, G., Muschiol, S., et al. (2020) · Cell · doi:10.1016/j.cell.2020.08.017 · Cited by 1,788 · see citing works

Deep immune profiling of COVID-19 patients reveals distinct immunotypes with therapeutic implications

Mathew, D., Giles, J. R., Baxter, A. E., Oldridge, D. A., Greenplate, A. R., Wu, J. E., Alanio, C., Kuri-Cervantes, L., Pampena, M. B., D’Andrea, K., et al. (2020) · Science · doi:10.1126/science.abc8511 · Cited by 1,509 · see citing works

A single-cell atlas of the peripheral immune response in patients with severe COVID-19

Wilk, A. J., Rustagi, A., Zhao, N. Q., Roque, J., Martínez-Colón, G. J., McKechnie, J. L., Ivison, G. T., Ranganath, T., Vergara, R., Hollis, T., et al. (2020) · Nature Medicine · doi:10.1038/s41591-020-0944-y · Cited by 1,493 · see citing works

Sex differences in immune responses that underlie COVID-19 disease outcomes

Takahashi, T., Ellingson, M. K., Wong, P., Israelow, B., Lucas, C., Klein, J., Silva, J., Mao, T., Oh, J. E., Tokuyama, M., et al. (2020) · Nature · doi:10.1038/s41586-020-2700-3 · Cited by 1,459 · see citing works

SARS-CoV-2-reactive T cells in healthy donors and patients with COVID-19

Braun, J., Loyal, L., Frentsch, M., Wendisch, D., Georg, P., Kurth, F., Hippenstiel, S., Dingeldey, M., Kruse, B., Fauchere, F., et al. (2020) · Nature · doi:10.1038/s41586-020-2598-9 · Cited by 1,310 · see citing works

Sex differences in autoimmune disease

Whitacre, C. C. (2001) · Nature Immunology · doi:10.1038/ni0901-777 · Cited by 1,271 · see citing works

Broad and strong memory CD4+ and CD8+ T cells induced by SARS-CoV-2 in UK convalescent individuals following COVID-19

Peng, Y., Mentzer, A. J., Liu, G., Yao, X., Yin, Z., Dong, D., Dejnirattisai, W., Rostron, T., Supasa, P., Liu, C., et al. (2020) · Nature Immunology · doi:10.1038/s41590-020-0782-6 · Cited by 1,179 · see citing works

Selective and cross-reactive SARS-CoV-2 T cell epitopes in unexposed humans

Mateus, J., Grifoni, A., Tarke, A., Sidney, J., Ramirez, S. I., Dan, J. M., Burger, Z. C., Rawlings, S. A., Smith, D. M., Phillips, E., et al. (2020) · Science · doi:10.1126/science.abd3871 · Cited by 1,120 · see citing works

Detection of SARS-CoV-2-Specific Humoral and Cellular Immunity in COVID-19 Convalescent Individuals

Ni, L., Ye, F., Cheng, M., Yu, F., Deng, Y., Zhao, H. J., Peng, W., Ge, J., Gou, M., Li, X., et al. (2020) · Immunity · doi:10.1016/j.immuni.2020.04.023 · Cited by 1,069 · see citing works

Tissue-Resident Memory T Cells

Schenkel, J. M., & Masopust, D. (2014) · Immunity · doi:10.1016/j.immuni.2014.12.007 · Cited by 1,059 · cited 1× · see citing works

Immunological considerations for COVID-19 vaccine strategies

Jeyanathan, M., Afkhami, S., Smaill, F., Miller, M. S., Lichty, B. D., & Xing, Z. (2020) · Nature Reviews Immunology · doi:10.1038/s41577-020-00434-6 · Cited by 1,015 · see citing works

Breadth of concomitant immune responses prior to patient recovery: a case report of non-severe COVID-19

Thevarajan, I., Nguyen, T. H. O., Koutsakos, M., Druce, J. D., Caly, L., van de Sandt, C. E., Jia, X., Nicholson, S. R., Catton, M. C., Cowie, B., et al. (2020) · Nature Medicine · doi:10.1038/s41591-020-0819-2 · Cited by 993 · see citing works

A dynamic COVID-19 immune signature includes associations with poor prognosis

Laing, A. G., Lorenc, A., del Molino del Barrio, I., Das, A., Fish, M., Monin, L., Muñoz-Ruiz, M., McKenzie, D. R., Hayday, T. S., Francos-Quijorna, I., et al. (2020) · Nature Medicine · doi:10.1038/s41591-020-1038-6 · Cited by 946 · see citing works

Phenotype and kinetics of SARS-CoV-2-specific T cells in COVID-19 patients with acute respiratory distress syndrome

Weiskopf, D., Schmitz, K. S., Raadsen, M. P., Grifoni, A., Okba, N. M. A., Endeman, H., van den Akker, J. P. C., Molenkamp, R., Koopmans, M. P. G., van Gorp, E. C. M., et al. (2020) · Science Immunology · doi:10.1126/sciimmunol.abd2071 · Cited by 907 · see citing works

Human memory T cells: generation, compartmentalization and homeostasis

Farber, D. L., Yudanin, N. A., & Restifo, N. P. (2014) · Nature Reviews Immunology · doi:10.1038/nri3567 · Cited by 897 · see citing works

Loss of Bcl-6-Expressing T Follicular Helper Cells and Germinal Centers in COVID-19

Kaneko, N., Kuo, H.-H., Boucau, J., Farmer, J. R., Allard-Chamard, H., Mahajan, V. S., Piechocka-Trocha, A., Lefteri, K., Osborn, M., Bals, J., et al. (2020) · Cell · doi:10.1016/j.cell.2020.08.025 · Cited by 734 · see citing works

Comprehensive mapping of immune perturbations associated with severe COVID-19

Kuri-Cervantes, L., Pampena, M. B., Meng, W., Rosenfeld, A. M., Ittner, C. A. G., Weisman, A. R., Agyekum, R. S., Mathew, D., Baxter, A. E., Vella, L. A., et al. (2020) · Science Immunology · doi:10.1126/sciimmunol.abd7114 · Cited by 723 · see citing works

Quantifying Memory CD8 T Cells Reveals Regionalization of Immunosurveillance

Steinert, E. M., Schenkel, J. M., Fraser, K. A., Beura, L. K., Manlove, L. S., Igyártó, B. Z., Southern, P. J., & Masopust, D. (2015) · Cell · doi:10.1016/j.cell.2015.03.031 · Cited by 685 · see citing works

Effects of COVID-19 on the Nervous System

Iadecola, C., Anrather, J., & Kamel, H. (2020) · Cell · doi:10.1016/j.cell.2020.08.028 · Cited by 663 · see citing works

SARS-CoV-2-derived peptides define heterologous and COVID-19-induced T cell recognition

Nelde, A., Bilich, T., Heitmann, J. S., Maringer, Y., Salih, H. R., Roerden, M., Lübke, M., Bauer, J., Rieth, J., Wacker, M., et al. (2021) · Nature Immunology · doi:10.1038/s41590-020-00808-x · Cited by 582 · see citing works

Prevention of tuberculosis in macaques after intravenous BCG immunization

Darrah, P. A., Zeppa, J. J., Maiello, P. A., Hackney, J. A., Wadsworth, M. H., Hughes, T. K., Pokkali, S., Swanson, P. A., Grant, N. L., Rodgers, M., et al. (2020) · Nature · doi:10.1038/s41586-019-1817-8 · Cited by 573 · see citing works

Covid-19 and autoimmunity

Ehrenfeld, M., Tincani, A., Andréoli, L., Cattalini, M., Greenbaum, A., Kanduc, D., Alijotas‐Reig, J., Zinserling, V. A., Semenova, N. Y., Amital, H., et al. (2020) · Autoimmunity Reviews · doi:10.1016/j.autrev.2020.102597 · Cited by 565 · see citing works

Imbalance of Regulatory and Cytotoxic SARS-CoV-2-Reactive CD4+ T Cells in COVID-19

Meckiff, B. J., Ramírez-Suástegui, C., Fajardo, V., Chee, S., Kusnadi, A., Simon, H. A., Eschweiler, S., Grifoni, A., Pelosi, E., Weiskopf, D., et al. (2020) · Cell · doi:10.1016/j.cell.2020.10.001 · Cited by 565 · see citing works

Human Leukocyte Antigen Susceptibility Map for Severe Acute Respiratory Syndrome Coronavirus 2

Nguyen, A., David, J. K., Maden, S. K., Wood, M. A., Weeder, B. R., Nellore, A., & Thompson, R. F. (2020) · Journal of Virology · doi:10.1128/jvi.00510-20 · Cited by 562 · see citing works

Nucleoside-modified mRNA vaccines induce potent T follicular helper and germinal center B cell responses

Pardi, N., Hogan, M. J., Naradikian, M. S., Parkhouse, K., Cain, D. W., Jones, L., Moody, M. A., Verkerke, H. P., Myles, A., Willis, E., et al. (2018) · Journal of Experimental Medicine · doi:10.1084/jem.20171450 · Cited by 530 · see citing works

Lack of Peripheral Memory B Cell Responses in Recovered Patients with Severe Acute Respiratory Syndrome: A Six-Year Follow-Up Study

Tang, F., Quan, Y., Xin, Z.-T., Wrammert, J., Ma, M.-J., Lv, H., Wang, T.-B., Yang, H., Richardus, J. H., Liu, W., et al. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.0903490 · Cited by 496 · see citing works

Airway Memory CD4+ T Cells Mediate Protective Immunity against Emerging Respiratory Coronaviruses

Zhao, J., Zhao, J., Mangalam, A. K., Channappanavar, R., Fett, C., Meyerholz, D. K., Agnihothram, S., Baric, R. S., David, C. S., & Perlman, S. (2016) · Immunity · doi:10.1016/j.immuni.2016.05.006 · Cited by 496 · see citing works

Humoral and circulating follicular helper T cell responses in recovered patients with COVID-19

Juno, J. A., Tan, H.-X., Lee, W. S., Reynaldi, A., Kelly, H. G., Wragg, K., Esterbauer, R., Kent, H. E., Batten, C. J., Mordant, F. L., et al. (2020) · Nature Medicine · doi:10.1038/s41591-020-0995-0 · Cited by 437 · see citing works

Generation of a Broadly Useful Model for COVID-19 Pathogenesis, Vaccination, and Treatment

Sun, J., Zhuang, Z., Zheng, J. H., Li, K., Wong, R. L.-Y., Liu, D., Huang, J., He, J., Zhu, A., Zhao, J., et al. (2020) · Cell · doi:10.1016/j.cell.2020.06.010 · Cited by 434 · see citing works

The CD8 T Cell Response to Respiratory Virus Infections

Schmidt, M. E., & Varga, S. M. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.00678 · Cited by 371 · see citing works

Longitudinal profiling of respiratory and systemic immune responses reveals myeloid cell-driven lung inflammation in severe COVID-19

Szabo, P. A., Dogra, P., Gray, J. I., Wells, S. B., Connors, T. J., Weisberg, S. P., Krupska, I., Matsumoto, R., Poon, M. M. L., Idzikowski, E., et al. (2021) · Immunity · doi:10.1016/j.immuni.2021.03.005 · Cited by 371 · see citing works

Immune responses to SARS-CoV-2 infection in hospitalized pediatric and adult patients

Pierce, C. A., Preston‐Hurlburt, P., Dai, Y., Aschner, C. B., Cheshenko, N., Galen, B. T., Garforth, S., Herrera, N. G., Jangra, R. K., Morano, N. C., et al. (2020) · Science Translational Medicine · doi:10.1126/scitranslmed.abd5487 · Cited by 353 · see citing works

Original antigenic sin impairs cytotoxic T lymphocyte responses to viruses bearing variant epitopes

Klenerman, P., & Zinkernagel, R. M. (1998) · Nature · doi:10.1038/28860 · Cited by 349 · see citing works

T Cell Responses Are Required for Protection from Clinical Disease and for Virus Clearance in Severe Acute Respiratory Syndrome Coronavirus-Infected Mice

Zhao, J., Zhao, J., & Perlman, S. (2010) · Journal of Virology · doi:10.1128/jvi.01049-10 · Cited by 340 · see citing works

Dynamics of influenza-induced lung-resident memory T cells underlie waning heterosubtypic immunity

Slütter, B., Budimir, N., Abboud, G., Varga, S. M., Salek‐Ardakani, S., & Harty, J. T. (2017) · Science Immunology · doi:10.1126/sciimmunol.aag2031 · Cited by 297 · see citing works

Resident memory CD8+ T cells in the upper respiratory tract prevent pulmonary influenza virus infection

Pizzolla, A., Nguyen, T. H. O., Smith, J. M., Brooks, A., Kedzierska, K., Heath, W., Reading, P., & Wakim, L. (2017) · Science immunology · doi:10.1126/sciimmunol.aam6970 · Cited by 284 · see citing works

The lasting misery of coronavirus long-haulers

Marshall, M. (2020) · Nature · doi:10.1038/d41586-020-02598-6 · Cited by 282 · see citing works

Generation and persistence of human tissue-resident memory T cells in lung transplantation

Snyder, M. E., Finlayson, M. O., Connors, T. J., Dogra, P., Senda, T., Bush, E. C., Carpenter, D. J., Marboe, C. C., Benvenuto, L. J., Shah, L., et al. (2019) · Science Immunology · doi:10.1126/sciimmunol.aav5581 · Cited by 281 · see citing works

Generation of both cross-reactive and virus-specific T-cell populations after immunization with serologically distinct influenza A viruses.

Effros, R. B., Doherty, P. C., Gerhard, W., & Bennink, J. R. (1977) · The Journal of Experimental Medicine · doi:10.1084/jem.145.3.557 · Cited by 280 · see citing works

Cross-reactive memory T cells and herd immunity to SARS-CoV-2

Lipsitch, M., Grad, Y. H., Sette, A., & Crotty, S. (2020) · Nature Reviews Immunology · doi:10.1038/s41577-020-00460-4 · Cited by 260 · see citing works

Induction of Partial Specific Heterotypic Immunity in Mice by a Single Infection with Influenza A Virus

Schulman, J. L., & Kilbourne, E. D. (1965) · Journal of Bacteriology · doi:10.1128/jb.89.1.170-174.1965 · Cited by 241 · see citing works

Immune Responses to Middle East Respiratory Syndrome Coronavirus During the Acute and Convalescent Phases of Human Infection

Shin, H., Kim, Y., Kim, G., Lee, J. Y., Jeong, I., Joh, J.-S., Kim, H., Chang, E., Sim, S. Y., Park, J.-S., et al. (2018) · Clinical Infectious Diseases · doi:10.1093/cid/ciy595 · Cited by 148 · see citing works

HLA-B*44 and C*01 Prevalence Correlates with Covid19 Spreading across Italy

Correale, P., Mutti, L., Pentimalli, F., Baglìo, G., Saladino, R. E., Sileri, P., & Giordano, A. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21155205 · Cited by 107 · see citing works

Long-term human coronavirus-myelin cross-reactive T-cell clones derived from multiple sclerosis patients

Boucher, A., Desforges, M., Duquette, P., & Talbot, P. J. (2007) · Clinical Immunology · doi:10.1016/j.clim.2007.02.002 · Cited by 95 · see citing works

Long covid could be four different syndromes, review suggests

Mahase, E. (2020) · BMJ · doi:10.1136/bmj.m3981 · Cited by 70 · see citing works

Author Correction: A dynamic COVID-19 immune signature includes associations with poor prognosis

Laing, A. G., Lorenc, A., del Barrio, I. D. M., Das, A., Fish, M., Monin, L., Muñoz‐Ruiz, M., McKenzie, D. R., Hayday, T. S., Francos-Quijorna, I., et al. (2020) · Nature Medicine · doi:10.1038/s41591-020-01186-5 · Cited by 68 · see citing works

COVID-19: Infection or Autoimmunity

Icenogle, T. B. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.02055 · Cited by 53 · see citing works

Analysis of respiratory and systemic immune responses in COVID-19 reveals mechanisms of disease pathogenesisPreprint

Szabo, P. A., Dogra, P., Gray, J. I., et al. (2020) · medRxiv · doi:10.1101/2020.10.15.20208041 · Cited by 25 · see citing works

Long COVID or post-COVID-19 syndrome: putative pathophysiology, risk factors, and treatments

Yong, S. J. (2021) · Infectious Diseases · doi:10.1080/23744235.2021.1924397 · Cited by 1,339 · see citing works

SARS-CoV-2 infection of the oral cavity and saliva

Huang, N., Pérez, P., Kato, T., Mikami, Y., Okuda, K., Gilmore, R. C., Conde, C. D., Gasmi, B., Stein, S. R., Beach, M. E., et al. (2021) · Nature Medicine · doi:10.1038/s41591-021-01296-8 · Cited by 789 · see citing works

CD8+ T cells contribute to survival in patients with COVID-19 and hematologic cancer

Bange, E. M., Han, N. A., Wileyto, P., Kim, J. Y., Gouma, S., Robinson, J., Greenplate, A. R., Hwee, M. A., Porterfield, F., Owoyemi, O., et al. (2021) · Nature Medicine · doi:10.1038/s41591-021-01386-7 · Cited by 519 · see citing works

The dawn of mRNA vaccines: the COVID-19 case

Verbeke, R., Lentacker, I., De Smedt, S. C., & Dewitte, H. (2021) · Journal of Controlled Release · doi:10.1016/j.jconrel.2021.03.043 · Cited by 504 · see citing works

SARS-CoV-2 human T cell epitopes: Adaptive immune response against COVID-19

Grifoni, A., Sidney, J., Vita, R., Peters, B., Crotty, S., Weiskopf, D., & Sette, A. (2021) · Cell Host & Microbe · doi:10.1016/j.chom.2021.05.010 · Cited by 314 · see citing works

Lipid nanoparticles for delivery of RNA therapeutics: Current status and the role of <i>in vivo</i> imaging

Jung, H. N., Lee, S.-Y., Lee, S., Youn, H., & Im, H.-J. (2022) · Theranostics · doi:10.7150/thno.77259 · Cited by 282 · see citing works

Activation or exhaustion of CD8+ T cells in patients with COVID-19

Rha, M., & Shin, E. (2021) · Cellular and Molecular Immunology · doi:10.1038/s41423-021-00750-4 · Cited by 193 · see citing works

CD8+ T cells specific for an immunodominant SARS-CoV-2 nucleocapsid epitope cross-react with selective seasonal coronaviruses

Lineburg, K. E., Grant, E. J., Swaminathan, S., Chatzileontiadou, D. S. M., Szeto, C., Sloane, H., Panikkar, A., Raju, J., Crooks, P., Rehan, S., et al. (2021) · Immunity · doi:10.1016/j.immuni.2021.04.006 · Cited by 183 · see citing works

SARS-CoV-2-specific antibody and T-cell responses 1 year after infection in people recovered from COVID-19: a longitudinal cohort study

Guo, L., Wang, G., Wang, Y., Zhang, Q., Ren, L., Gu, X., Huang, T., Zhong, J., Wang, Y., Wang, X., et al. (2022) · The Lancet Microbe · doi:10.1016/s2666-5247(22)00036-2 · Cited by 169 · see citing works

Post-COVID-19 syndrome, low-grade inflammation and inflammatory markers: a cross-sectional study

Maamar, M., Artime, A., Rodrigo, E., Fierro, P., Ruiz, Y., Gutiérrez, S., González, R., Bustamante, E., Pinedo, G., Rodríguez, B., et al. (2022) · Current Medical Research and Opinion · doi:10.1080/03007995.2022.2042991 · Cited by 164 · see citing works

S1-Leitlinie Post-COVID/Long-COVID

Koczulla, A. R., Ankermann, T., Behrends, U., Berlit, P., Böing, S., Brinkmann, F., Franke, C., Glöckl, R., Gogoll, C., Hummel, T. R., et al. (2021) · Pneumologie · doi:10.1055/a-1551-9734 · Cited by 161 · see citing works

A core-shell structured COVID-19 mRNA vaccine with favorable biodistribution pattern and promising immunity

Yang, R., Deng, Y., Huang, B., Huang, L., Lin, A., Li, Y., Wang, W., Liu, J., Lu, S., Zhan, Z., et al. (2021) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-021-00634-z · Cited by 130 · see citing works

Gut Microbiome Alterations in COVID-19

Zuo, T., Wu, X., Wen, W., & Lan, P. (2021) · Genomics Proteomics & Bioinformatics · doi:10.1016/j.gpb.2021.09.004 · Cited by 132 · see citing works

SARS-CoV-2 triggering autoimmune diseases

Mobasheri, L., Nasirpour, M. H., Masoumi, E., Azarnaminy, A. F., Jafari, M., & Esmaeili, S. (2022) · Cytokine · doi:10.1016/j.cyto.2022.155873 · Cited by 125 · see citing works

Long COVID and rehabilitation

Chuang, H., Lin, C.-W., Hsiao, M., Wang, T., & Liang, H. (2023) · Journal of the Formosan Medical Association · doi:10.1016/j.jfma.2023.03.022 · Cited by 125 · see citing works

COVID-19 vaccination and antirheumatic therapy

Arnold, J., Winthrop, K. L., & Emery, P. (2021) · Lara D. Veeken · doi:10.1093/rheumatology/keab223 · Cited by 114 · see citing works

Engineering of the current nucleoside-modified mRNA-LNP vaccines against SARS-CoV-2

Granados-Riveron, J. T., & Aquino‐Jarquín, G. (2021) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2021.111953 · Cited by 115 · see citing works

S1-Leitlinie Long-/Post-COVID

Koczulla, A. R., Ankermann, T., Behrends, U., Berlit, P., Berner, R., Böing, S., Brinkmann, F., Frank, U., Franke, C., Glöckl, R., et al. (2022) · Pneumologie · doi:10.1055/a-1946-3230 · Cited by 111 · see citing works

Boosting with heterologous vaccines effectively improves protective immune responses of the inactivated SARS-CoV-2 vaccine

Zhang, J., He, Q., An, C., Mao, Q., Gao, F., Bian, L., Xing, W., Wang, Q., Liu, P., Song, L., et al. (2021) · Emerging Microbes & Infections · doi:10.1080/22221751.2021.1957401 · Cited by 95 · see citing works

SARS‑CoV-2 RBD219-N1C1: A yeast-expressed SARS-CoV-2 recombinant receptor-binding domain candidate vaccine stimulates virus neutralizing antibodies and T-cell immunity in mice

Pollet, J. B. K., Chen, W., Versteeg, L., Keegan, B. P., Zhan, B., Wei, J., Liu, Z., Lee, J., Kundu, R., Adhikari, R., et al. (2021) · Human Vaccines & Immunotherapeutics · doi:10.1080/21645515.2021.1901545 · Cited by 96 · see citing works

Impaired health-related quality of life in long-COVID syndrome after mild to moderate COVID-19

Malesevic, S., Sievi, N. A., Baumgartner, P., Roser, K., Sommer, G., Schmidt, D., Vallelian, F., Jelčić, I., Clarenbach, C. F., & Kohler, M. (2023) · Scientific Reports · doi:10.1038/s41598-023-34678-8 · Cited by 99 · see citing works

COVID‐19 is getting on our nerves: sympathetic neural activity and haemodynamics in young adults recovering from SARS‐CoV‐2

Stute, N. L., Stickford, J. L., Province, V. M., Augenreich, M. A., Ratchford, S. M., & Stickford, A. S. L. (2021) · The Journal of Physiology · doi:10.1113/jp281888 · Cited by 86 · see citing works

Functionality, physical activity, fatigue and quality of life in patients with acute COVID-19 and Long COVID infection

Vélez-Santamaría, R., Fernández-Solana, J., Méndez-López, F., García, M. D., Gonzalez-Bernal, J. J., Magallón-Botaya, R. M., Oliván‐Blázquez, B., González‐Santos, J., & Santamaría‐Peláez, M. (2023) · Scientific Reports · doi:10.1038/s41598-023-47218-1 · Cited by 74 · see citing works

COVID-19 and chronic fatigue syndrome: An endocrine perspective

Bansal, R., Gubbi, S., & Koch, C. A. (2021) · Journal of Clinical & Translational Endocrinology · doi:10.1016/j.jcte.2021.100284 · Cited by 74 · see citing works

The T-cell response to SARS-CoV-2: kinetic and quantitative aspects and the case for their protective role

Bertoletti, A., Tan, A. T., & Bert, N. L. (2021) · Oxford Open Immunology · doi:10.1093/oxfimm/iqab006 · Cited by 67 · see citing works

Human mucosal tissue-resident memory T cells in health and disease

Lange, J. L., Rivera‐Ballesteros, O., & Buggert, M. (2021) · Mucosal Immunology · doi:10.1038/s41385-021-00467-7 · Cited by 70 · see citing works

Oral Pathology in COVID-19 and SARS-CoV-2 Infection—Molecular Aspects

Droździk, A., & Droździk, M. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23031431 · Cited by 63 · see citing works

A behavioural modelling approach to assess the impact of COVID-19 vaccine hesitancy

Buonomo, B., Marca, R. D., d’Onofrio, A., & Groppi, M. (2021) · Journal of Theoretical Biology · doi:10.1016/j.jtbi.2021.110973 · Cited by 54 · see citing works

Pathogenesis of taste impairment and salivary dysfunction in COVID-19 patients

Okada, Y., Yoshimura, K., Toya, S., & Tsuchimochi, M. (2021) · Japanese Dental Science Review · doi:10.1016/j.jdsr.2021.07.001 · Cited by 55 · see citing works

Post-COVID-19 Condition: Where Are We Now?

Boaventura, P., Macedo, S., Ribeiro, F. M., Jaconiano, S., & Soares, P. (2022) · Life · doi:10.3390/life12040517 · Cited by 53 · see citing works

Thymic Aging May Be Associated with COVID-19 Pathophysiology in the Elderly

Wang, W., Thomas, R. G., Oh, J., & Su, D. (2021) · Cells · doi:10.3390/cells10030628 · Cited by 52 · see citing works

Current and prospective computational approaches and challenges for developing COVID-19 vaccines

Hwang, W., Lei, W., Katritsis, N. M., MacMahon, M., Chapman, K. L., & Han, N. (2021) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2021.02.004 · Cited by 48 · see citing works

An update review of globally reported SARS-CoV-2 vaccines in preclinical and clinical stages

Motamedi, H., Ari, M. M., Dashtbin, S., Fathollahi, M., Hossainpour, H., Alvandi, A., Moradi, J., & Abiri, R. (2021) · International Immunopharmacology · doi:10.1016/j.intimp.2021.107763 · Cited by 49 · see citing works

Plausibility of a third wave of COVID-19 in India

Mandal, S., Arinaminpathy, N., Bhargava, B., & Panda, S. (2021) · The Indian Journal of Medical Research · doi:10.4103/ijmr.ijmr_1627_21 · Cited by 49 · see citing works

Living with Covid19 – Second review

(2021) · doi:10.3310/themedreview_45225 · Cited by 48 · see citing works

T‐cell recovery and evidence of persistent immune activation 12 months after severe COVID ‐19

Taeschler, P., Adamo, S., Deng, Y., Cervia, C., Zurbuchen, Y., Chevrier, S., Raeber, M. E., Hasler, S., Bächli, E., Rudiger, A., et al. (2022) · Allergy · doi:10.1111/all.15372 · Cited by 48 · see citing works

Machine learning identifies T cell receptor repertoire signatures associated with COVID-19 severity

Park, J. J.-Y., Lee, K. A. V., Lam, S. Z., Moon, K. S., Fang, Z., & Chen, S. (2023) · Communications Biology · doi:10.1038/s42003-023-04447-4 · Cited by 46 · see citing works

Gut Microbiota Dynamics in Relation to Long-COVID-19 Syndrome: Role of Probiotics to Combat Psychiatric Complications

Alenazy, M. F., Aljohar, H. I., Alruwaili, A. R., Daghestani, M. H., Alonazi, M. A., Labban, R. S. M., El‐Ansary, A. K., & Balto, H. A. G. (2022) · Metabolites · doi:10.3390/metabo12100912 · Cited by 38 · see citing works

Single-cell RNA sequencing reveals ex vivo signatures of SARS-CoV-2-reactive T cells through ‘reverse phenotyping’

Fischer, D. S., Ansari, M., Wagner, K. I., Jarosch, S., Huang, Y., Mayr, C. H., Strunz, M., Lang, N. J., D’Ippolito, E., Hammel, M., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-24730-4 · Cited by 37 · see citing works

Nanocarrier vaccine therapeutics for global infectious and chronic diseases

Simnani, F. Z., Singh, D., Patel, P., Choudhury, A., Sinha, A., Nandi, A., Samal, S. K., Verma, S. K., & Panda, P. K. (2023) · Materials Today · doi:10.1016/j.mattod.2023.04.008 · Cited by 37 · see citing works

Treatment of COVID-19 during the Acute Phase in Hospitalized Patients Decreases Post-Acute Sequelae of COVID-19

Bonet, D. B., Caguana-Vélez, O. A., Durán, X., Comas, M., Posso, M., Admetlló, M., Blasco, A. H., Cuadrado‐Godia, E., Marco, E., Martín‐Ezquerra, G., et al. (2023) · Journal of Clinical Medicine · doi:10.3390/jcm12124158 · Cited by 33 · see citing works

Cardiac Manifestations of Post-Acute COVID-19 Infection

Mohammad, K. O., Lin, A., & Rodriguez, J. B. C. (2022) · Current Cardiology Reports · doi:10.1007/s11886-022-01793-3 · Cited by 29 · see citing works

COVID-19 and Dentistry in 72 Questions: An Overview of the Literature

Derruau, S., Bouchet, J., Nassif, A., Baudet, A., Yasukawa, K., Lorimier, S., Prêcheur, I., Bloch‐Zupan, A., Pellat, B., Chardin, H., et al. (2021) · Journal of Clinical Medicine · doi:10.3390/jcm10040779 · Cited by 28 · see citing works

Persistent Symptoms After Acute COVID-19 Infection in Omicron Era

Jung, Y. H., Ha, E.-H., Choe, K. W., Lee, S., Jo, D. H., & Lee, W. J. (2022) · Journal of Korean Medical Science · doi:10.3346/jkms.2022.37.e213 · Cited by 27 · see citing works

PD-1/PD-L1 blockade abrogates a dysfunctional innate-adaptive immune axis in critical β-coronavirus disease

Vega, M. D., Olivera, D., Davanzo, G. G., Bertullo, M., Noya, V., de Souza, G. F., Muraro, S. P., de Castro, Í. M. S., Arévalo, A. P., Crispo, M., et al. (2022) · Science Advances · doi:10.1126/sciadv.abn6545 · Cited by 25 · see citing works

Computational, Experimental, and Clinical Evidence of a Specific but Peculiar Evolutionary Nature of (COVID-19) SARS-CoV-2

Goh, G. K., Dunker, A. K., Foster, J. A., & Uversky, V. N. (2022) · Journal of Proteome Research · doi:10.1021/acs.jproteome.2c00001 · Cited by 23 · see citing works

Role of Nuclear Factor Erythroid 2 (Nrf2) in the Recovery of Long COVID-19 Using Natural Antioxidants: A Systematic Review

Muchtaridi, M., Amirah, S. R., Harmonis, J. A., & Ikram, E. H. K. (2022) · Antioxidants · doi:10.3390/antiox11081551 · Cited by 25 · see citing works

Science's Response to CoVID‐19

Long, M. J. C., & Aye, Y. (2021) · ChemMedChem · doi:10.1002/cmdc.202100079 · Cited by 22 · see citing works

Nasal Administration of Anti-CD3 Monoclonal Antibody (Foralumab) Reduces Lung Inflammation and Blood Inflammatory Biomarkers in Mild to Moderate COVID-19 Patients: A Pilot Study

Moreira, T. G., Matos, K. T. F., Paula, G. S. D., Santana, T. M. M., Mata, R. G. D., Pansera, F. C., Cortina, A. S., Spinola, M. G., Baecher‐Allan, C., Keppeke, G. D., et al. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.709861 · Cited by 22 · see citing works

COVID-19 in Patients with Hematologic Malignancies: Clinical Manifestations, Persistence, and Immune Response

Gur, I., Giladi, A., Isenberg, Y. N., Neuberger, A., & Stern, A. (2022) · Acta Haematologica · doi:10.1159/000523872 · Cited by 22 · see citing works

Long-term humoral and cellular immunity after primary SARS-CoV-2 infection: a 20-month longitudinal study

Hvidt, A. K., Guo, H., Andersen, R., Nielsen, S. S. F., Vibholm, L. K., Søgaard, O. S., Schleimann, M. H., Russell, V. R., Cheung, A. M., Paramithiotis, E., et al. (2023) · BMC Immunology · doi:10.1186/s12865-023-00583-y · Cited by 21 · see citing works

Landscape of T‐cell repertoires with public COVID‐19‐associated T‐cell receptors in pre‐pandemic risk cohorts

Simnica, D., Schultheiß, C., Mohme, M., Paschold, L., Willscher, E., Fitzek, A., Püschel, K., Matschke, J., Ciesek, S., Sedding, D., et al. (2021) · Clinical & Translational Immunology · doi:10.1002/cti2.1340 · Cited by 21 · see citing works

Nasal administration of anti-CD3 mAb (Foralumab) downregulates NKG7 and increases TGFB1 and GIMAP7 expression in T cells in subjects with COVID-19

Moreira, T. G., Gauthier, C. D., Murphy, L., Lanser, T. B., Paul, A., Matos, K. T. F., Mangani, D., Izzy, S., Rezende, R. M., Healy, B. C., et al. (2023) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2220272120 · Cited by 20 · see citing works

India’s pragmatic vaccination strategy against COVID-19: a mathematical modelling-based analysis

Mandal, S., Arinaminpathy, N., Bhargava, B., & Panda, S. (2021) · BMJ Open · doi:10.1136/bmjopen-2021-048874 · Cited by 20 · see citing works

Long-term immunologic effects of SARS-CoV-2 infection: leveraging translational research methodology to address emerging questions

Peluso, M. J., Donatelli, J. L., & Henrich, T. J. (2021) · Translational research · doi:10.1016/j.trsl.2021.11.006 · Cited by 16 · see citing works

COVID-19 in German Competitive Sports: Protocol for a Prospective Multicenter Cohort Study (CoSmo-S)

Niess, A. M., Widmann, M., Gaidai, R., Gölz, C., Schubert, I., Castillo, K., Sachs, J. P., Bizjak, D. A., Vollrath, S., Wimbauer, F., et al. (2022) · International Journal of Public Health · doi:10.3389/ijph.2022.1604414 · Cited by 19 · see citing works

Different humoral but similar cellular responses of patients with autoimmune inflammatory rheumatic diseases under disease-modifying antirheumatic drugs after COVID-19 vaccination

Andreica, I., Blazquez‐Navarro, A., Sokolar, J., Anft, M., Kiltz, U., Pfaender, S., Blanco, E. V., Westhoff, T. H., Babel, N., Stervbo, U., et al. (2022) · RMD Open · doi:10.1136/rmdopen-2022-002293 · Cited by 19 · see citing works

Post-COVID-Syndrom – Fokus Fatigue

Hellwig, S., & Domschke, K. (2022) · Der Nervenarzt · doi:10.1007/s00115-022-01306-1 · Cited by 18 · see citing works

Microbiota as a potentially-modifiable factor influencing COVID-19

Ngo, V. L., & Gewirtz, A. T. (2021) · Current Opinion in Virology · doi:10.1016/j.coviro.2021.04.005 · Cited by 18 · see citing works

Mutations in spike protein T cell epitopes of SARS-COV-2 variants: Plausible influence on vaccine efficacy

Sankaranarayanan, S., Mohkhedkar, M., & Vani, J. (2022) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2022.166432 · Cited by 18 · see citing works

Efectos a largo plazo de la COVID-19: una revisión de la literatura

Wong‐Chew, R. M., Angel-Ambrocio, A. H., Carbajal, P. B., León, M. L. G., Velázquez, X. V., Maldonado, L. A. C., Ramírez, J. B. D., González, Y. V., Martínez, L. M. V., Osorno, Z. R. G., et al. (2021) · Acta Médica Grupo Ángeles · doi:10.35366/101741 · Cited by 16 · see citing works

The Potential Role of Viral Persistence in the Post-Acute Sequelae of SARS-CoV-2 Infection (PASC)

Lupi, L., Vitiello, A., Parolin, C., Calistri, A., & Demo, A. G. (2024) · Pathogens · doi:10.3390/pathogens13050388 · Cited by 16 · see citing works

Impaired SARS-CoV-2 specific T-cell response in patients with severe COVID-19

Rümke, L. W., Smit, W. L., Bossink, A. W. J., Limonard, G. J. M., Muilwijk, D., Haas, L. E. M., Reusken, C. B. E. M., van der Wal, S., Thio, B. J., van Os, Y. M. G., et al. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1046639 · Cited by 14 · see citing works

Long COVID in Children, Adults, and Vulnerable Populations: A Comprehensive Overview for an Integrated Approach

Calcaterra, V., Zanelli, S., Foppiani, A., Verduci, E., Benatti, B., Bollina, R., Bombaci, F., Brucato, A. L., Cammarata, S., Calabrò, E., et al. (2024) · Diseases · doi:10.3390/diseases12050095 · Cited by 16 · see citing works

Liver disorders in COVID-19, nutritional approaches and the use of phytochemicals

Vargas-Mendoza, N., García‐Machorro, J., Ángeles-Valencia, M., Martínez‐Archundia, M., Madrigal‐Santillán, E., Morales‐González, Á., Anguiano‐Robledo, L., & Morales‐González, J. A. (2021) · World Journal of Gastroenterology · doi:10.3748/wjg.v27.i34.5630 · Cited by 14 · see citing works

Functional outcomes in post Covid-19 patients with persistent dyspnea: multidisciplinary approach

Hamdy, R. M., Elaziz, O. H. A., Shamsseldain, H. E., & Eltrawy, H. H. (2023) · The International Journal of Cardiovascular Imaging · doi:10.1007/s10554-023-02819-9 · Cited by 13 · see citing works

Bamlanivimab therapy for acute COVID-19 does not blunt SARS-CoV-2–specific memory T cell responses

Ramirez, S. I., Grifoni, A., Weiskopf, D., Parikh, U. M., Heaps, A., Faraji, F., Sieg, S. F., Ritz, J., Moser, C., Eron, J. J., et al. (2022) · JCI Insight · doi:10.1172/jci.insight.163471 · Cited by 13 · see citing works

European Working Group on SARS-CoV-2: Current Understanding, Unknowns, and Recommendations on the Neurological Complications of COVID-19

Crook, H., Ramı́rez, A., Hosseini, A. A., Vavougios, G. D., Lehmann, C., Bruchfeld, J., Schneider, A., d’Avossa, G., Re, V. L., Salmoiraghi, A., et al. (2023) · Brain Connectivity · doi:10.1089/brain.2022.0058 · Cited by 12 · see citing works

Polysomnographic parameters in long-COVID chronic insomnia patients

Rouen, A., Taïeb, J., Caetano, G., Pitron, V., Elbaz, M., Salmon, D., & Léger, D. (2023) · Dialogues in Clinical Neuroscience · doi:10.1080/19585969.2023.2222714 · Cited by 12 · see citing works

Severity of COVID-19 infection in primary Sjögren's syndrome and the emerging evidence of COVID-19-induced xerostomia

Chowdhury, F., Grigoriadou, S., & Bombardieri, M. (2021) · Clinical and Experimental Rheumatology · doi:10.55563/clinexprheumatol/k7x3ta · Cited by 12 · see citing works

Long-term effects of SARS-CoV-2 infection in hospitalized children: findings from an Italian single-center study

Calcaterra, V., Tagi, V. M., D’Auria, E., Lai, A., Zanelli, S., Montanari, C., Biganzoli, E. M., Marano, G., Borghi, E., Massa, V., et al. (2024) · The Italian Journal of Pediatrics/Italian journal of pediatrics · doi:10.1186/s13052-024-01596-y · Cited by 11 · see citing works

Post-COVID-19 Fatigue and SARS-CoV-2 Specific Humoral and T-Cell Responses in Male and Female Outpatients

Meisinger, C., Goßlau, Y., Warm, T. D., Leone, V., Hyhlik-Dürr, A., Linseisen, J., & Kirchberger, I. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.902140 · Cited by 11 · see citing works

Hybrid molecules based on an emodin scaffold. Synthesis and activity against SARS-CoV-2 and Plasmodium

Li, Y., Touret, F., de Lamballerie, X. N., Nguyen, M., Laurent, M., Benoit‐Vical, F., Robert, A., Liu, Y., & Meunier, B. (2023) · Organic & Biomolecular Chemistry · doi:10.1039/d3ob01122d · Cited by 10 · see citing works

Post-akutes COVID-19 (“long-COVID”): Andauernde Symptome, mögliche Ursachen und symptomgeleitetes post-akut COVID-19 Management zur Wiedererlangung der körperlichen Leistungsfähigkeit (Scoping Review)

Puta, C., Haunhorst, S., & Bloch, W. (2021) · Sports Orthopaedics and Traumatology · doi:10.1016/j.orthtr.2021.08.006 · Cited by 10 · see citing works

Immunogenicity and risk of disease flare after a three-dose regimen with SARS-CoV-2 vaccination in patients with systemic lupus erythematosus: results from the prospective cohort study COVAC-SLE

Larsen, E. S., Nilsson, A. C., Möller, S., Voss, A., & Johansen, I. S. (2022) · Clinical and Experimental Rheumatology · doi:10.55563/clinexprheumatol/b8a6zb · Cited by 10 · see citing works

Multimodal probing of T-cell recognition with hexapod heterostructures

Huang, X., Meng, L., Cao, G., Promiński, A., Hu, Y., Yang, C., Chen, M., Shi, J., Gallagher, C., Cao, T., et al. (2024) · Nature Methods · doi:10.1038/s41592-023-02165-7 · Cited by 10 · see citing works

Virological and Clinical Determinants of the Magnitude of Humoral Responses to SARS-CoV-2 in Mild-Symptomatic Individuals

Pradenas, E., Ubals, M., Urrea, V., Suñer, C., Trinité, B., Riveira-Muñoz, E., Marfil, S., Ávila-Nieto, C., de la Concepción, M. L. R., Tarrés-Freixas, F., et al. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.860215 · Cited by 10 · see citing works

Hyperbaric oxygen effectively addresses the pathophysiology of long COVID: clinical review

Katz, A. A., Wainwright, S. K., Kelly, M. P., Albert, P., & Byrne, R. (2024) · Frontiers in Medicine · doi:10.3389/fmed.2024.1354088 · Cited by 8 · see citing works

CCR2 Regulates Vaccine-Induced Mucosal T-Cell Memory to Influenza A Virus

Lee, W., Kingstad-Bakke, B. A., Kedl, R. M., Kawaoka, Y., & Suresh, M. (2021) · Journal of Virology · doi:10.1128/jvi.00530-21 · Cited by 9 · see citing works

SARS-COV-2 as an artificial creation: scientific arguments and counterarguments

Yee, S., Tan, C. S., Khan, A. H., Lee, K. S., Goh, B. H., & Ming, L. C. (2021) · Journal of Medicine and Life · doi:10.25122/jml-2020-0175 · Cited by 9 · see citing works

Broad-spectrum coronavirus vaccines: integrated strategies to combat viral diversity

He, Q., Zhang, Y., Fu, Z., Ma, X., & Liang, Z. (2025) · Expert Review of Vaccines · doi:10.1080/14760584.2025.2538561 · Cited by 8 · see citing works

The Silent Syndrome of Long COVID and Gaps in Scientific Knowledge: A Narrative Review

da Silva, R., Vallinoto, A. C. R., & dos Santos, E. J. M. (2024) · Viruses · doi:10.3390/v16081256 · Cited by 8 · see citing works

COVID-19 vs. Cancer Immunosurveillance: A Game of Thrones within an Inflamed Microenviroment

Liapis, I., & Baritaki, S. (2022) · Cancers · doi:10.3390/cancers14174330 · Cited by 8 · see citing works

Antibody response to SARS-CoV-2 mRNA vaccination in Danish adults exposed to perfluoroalkyl substances (PFASs): The ENFORCE study

Timmermann, C. A. G., Johansen, I. S., Tolstrup, M., Heilmann, C. J., Budtz–Jørgensen, E., Tolstrup, J. S., Nielsen, F., & Grandjean, P. (2024) · Environmental Research · doi:10.1016/j.envres.2024.120039 · Cited by 7 · see citing works

COVID-19 on Oral Health: A New Bilateral Connection for the Pandemic

Bellocchio, L., Dipalma, G., Inchingolo, A. M., Inchingolo, A. D., Ferrante, L., Vecchio, G. D., Malcangi, G., Palermo, A., Qendro, A., & Inchingolo, F. (2023) · Biomedicines · doi:10.3390/biomedicines12010060 · Cited by 7 · see citing works

EpiCurator: an immunoinformatic workflow to predict and prioritize SARS-CoV-2 epitopes

Ferreira, C. D. S., Martins, Y., Souza, R. C., & de Vasconcelos, A. T. R. (2021) · PeerJ · doi:10.7717/peerj.12548 · Cited by 7 · see citing works

Prevalence of COVID-19-associated symptoms during acute infection in relation to SARS-CoV-2-directed humoral and cellular immune responses in a mild-diseased convalescent cohort

Tegeler, C. M., Bilich, T., Maringer, Y., Salih, H. R., Walz, J. S., Nelde, A., & Heitmann, J. S. (2022) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2022.04.019 · Cited by 7 · see citing works

Study of the Effects of Several SARS-CoV-2 Structural Proteins on Antiviral Immunity

Yue, R., Zeng, F., Ma, D., Meng, Z., Li, X., Zhang, Z., Zhang, H., Li, Q., Xu, L., Niu, Z., et al. (2023) · Vaccines · doi:10.3390/vaccines11030524 · Cited by 7 · see citing works

Designing of cytotoxic T lymphocyte-based multi-epitope vaccine against SARS-CoV2: a reverse vaccinology approach

Vivekanandam, R., Rajagopalan, K., Jeevanandam, M., Ganesan, H., Jagannathan, V., Christyraj, J. D. S., Kalishwaralal, K., Christyraj, J. R. S. S., & Mohan, M. (2021) · Journal of Biomolecular Structure and Dynamics · doi:10.1080/07391102.2021.1993338 · Cited by 7 · see citing works

Laser-facilitated epicutaneous immunization of mice with SARS-CoV-2 spike protein induces antibodies inhibiting spike/ACE2 binding

Scheiblhofer, S., Drothler, S., Braun, W., Braun, R., Boesch, M., & Weiss, R. (2021) · Vaccine · doi:10.1016/j.vaccine.2021.06.068 · Cited by 6 · see citing works

Circulating Adaptive Immune Cells Expressing the Gut Homing Marker α4β7 Integrin Are Decreased in COVID-19

Müller, T. M., Becker, E. M., Wiendl, M., Schulze, L. L., Voskens, C., Völkl, S., Kremer, A. E., Neurath, M. F., & Zundler, S. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.639329 · Cited by 6 · see citing works

Diagnostic Justice

Kennedy, A. G., & Cwik, B. (2021) · European journal of analytic philosophy · doi:10.31820/ejap.17.3.1 · Cited by 6 · see citing works

Severely ill and high-risk COVID-19 patients exhibit increased peripheral circulation of CD62L+ and perforin+ T cells

Lesteberg, K. E., Araya, P., Waugh, K. A., Chauhan, L., Espinosa, J. M., & Beckham, J. D. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1113932 · Cited by 7 · see citing works

mRNA vaccines against SARS-CoV-2 induce divergent antigen-specific T-cell responses in patients with lung cancer

Song, N., Chakravarthy, K. B., Jeon, H., Bolyard, C. M., Reynolds, K., Weller, K. P., Reisinger, S. A., Wang, Y., Li, A., Jiang, S., et al. (2024) · Journal for ImmunoTherapy of Cancer · doi:10.1136/jitc-2023-007922 · Cited by 6 · see citing works

Cellular and Humoral Immune Responses in Mice Immunized with Vaccinia Virus Expressing the SARS-CoV-2 Spike Protein

Harbour, J. C., Lyski, Z. L., Schell, J. B., Thomas, A., Messer, W. B., Slifka, M. K., & Nolz, J. C. (2021) · The Journal of Immunology · doi:10.4049/jimmunol.2100054 · Cited by 6 · see citing works

Changes in the Gut Microbiota of Patients After SARS-CoV-2 Infection: What Do We Know?

Arruda, I. D. S. A., Cavalcante, C. D. S., Rubens, R. S., Castro, L. H., Nóbrega, Y. K. D. M., & Dalmolin, T. V. (2025) · Microorganisms · doi:10.3390/microorganisms13112529 · Cited by 5 · see citing works

Humoral and Cellular Response and Associated Variables Nine Months following BNT162b2 Vaccination in Healthcare Workers

Syrimi, N., Sourri, F., Giannakopoulou, M.-C., Karamanis, D., Pantousas, A., Georgota, P., Rokka, E., Vladeni, Z., Tsiantoula, E., Soukara, E., et al. (2023) · Journal of Clinical Medicine · doi:10.3390/jcm12093172 · Cited by 5 · see citing works

The fourth vaccination with a non-SARS-CoV-2 variant adapted vaccine fails to increase the breadth of the humoral immune response

Hein, S., Sabino, C., Benz, N. I., Görgülü, E., Maier, T. J., Oberle, D., & Hildt, E. (2023) · Scientific Reports · doi:10.1038/s41598-023-38077-x · Cited by 5 · see citing works

COVID-19 and immunity: quo vadis?

Miyasaka, M. (2021) · International Immunology · doi:10.1093/intimm/dxab008 · Cited by 5 · see citing works

Male-Female Disparities in Years of Potential Life Lost Attributable to COVID-19 in the United States: A State-by-State Analysis

Xu, J. J., Chen, J. T., Belin, T. R., Brookmeyer, R., Suchard, M. A., & Ramirez, C. M. (2021) · Applied Sciences · doi:10.3390/app11167403 · Cited by 5 · see citing works

SARS-CoV-2-Specific T Cell Responses in Patients with COVID-19 and Unexposed Individuals

Rha, M., Kim, A. R., & Shin, E. (2021) · Immune Network · doi:10.4110/in.2021.21.e2 · Cited by 21 · see citing works

Editorial: Deciphering the T cell response in SARS-CoV-2 infection

Maggi, L., Mazzoni, A., & Biasi, S. D. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1419167 · Cited by 2 · see citing works

T cell immunity to SARS-CoV-2

Niessl, J., Sekine, T., & Buggert, M. (2021) · Seminars in Immunology · doi:10.1016/j.smim.2021.101505 · Cited by 74 · see citing works

Acute SARS-CoV-2 Infection Impairs Dendritic Cell and T Cell Responses

Zhou, R., To, K. K.-W., Wong, Y.-C., Liu, L., Zhou, B., Li, X., Huang, H., Mo, Y., Luk, T.-Y., Lau, T. T.-K., et al. (2020) · Immunity · doi:10.1016/j.immuni.2020.07.026 · Cited by 531 · see citing works

The interplay between dendritic cells and CD8 T lymphocytes is a crucial component of SARS-CoV-2 immunity

Buttenschoen, J., & Mattner, J. (2021) · Cellular and Molecular Immunology · doi:10.1038/s41423-020-00624-1 · Cited by 11 · see citing works